All forward-looking statements, including, without limitation, those relating to our operating trends and future financial performance, expense management, expectations for hiring and growth in our organization and our business, physician training and adoption, market opportunity and penetration, commercial and international expansion, regulatory approvals, reimbursement, competition, and product development are based upon our current estimates and various assumptions.

Feb 28, 2024 / CEO / receipt, needs a key / Chas McConn, CEO | earnings call 2024-02-28 | transcript 18c621fb-f126-4f01-b668-467fc10d6037 | chars 1455-1928 | segment 1